Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
2.7 HKD | -2.17% |
|
+0.37% | -22.19% |
06-25 | Sino Biopharmaceutical Gets NMPA's Nod for Marketing Diabetes Drug | MT |
06-25 | Sino Biopharmaceutical Limited Receives Approval for Marketing of Liraglutide Injection | CI |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registration![Consensus](/images/consensus_flch.gif)
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-22.19% | 6.48B | |
+54.61% | 811B | |
+43.85% | 640B | |
-6.33% | 353B | |
+20.62% | 333B | |
+10.44% | 302B | |
+18.02% | 246B | |
+2.62% | 225B | |
+12.74% | 218B | |
+8.61% | 168B |
- Stock Market
- Equities
- 1177 Stock
- News Sino Biopharmaceutical Limited
- Sino Biopharmaceutical Completes Issuance of 1.5 Billion Panda Bonds